Trump and other officials are boasting that the U.S. is now testing nearly 700,000 people each week for the coronavirus. But that’s not enough to catch every case or provide the data needed to lift social distancing measures and allow people back to work
A rapid test described by Trump in mid-March as a “game changer” that would soon be available in doctors offices is still hard to come by for many Americans.
Even then, some labs are struggling to meet demand. The commercial lab Quest Diagnostics had built up a backlog of 160,000 patient samples in California by late March. It has whittled that down to around 80,000 this week.two other groups should also be given priority And health departments in six states — Connecticut, Maryland, Mississippi, Nevada, New York and Washington — are using powers granted by the FDA to authorize labs within their borders to conduct coronavirus testing.Members of the American Clinical Laboratory Association, which include commercial labs such as Quest Diagnostics and LabCorp, have steadily added capacity to test patients. They’re now analyzing more than 100,000 tests each day.
Public health labs are also hampered by scarce testing supplies. Ongoing efforts by HHS testing czar Brett Giroir to make commercial test kits available through a CDC distribution system could help labs stay stocked, said Scott Becker, CEO of the Association of Public Health Laboratories. But officials at public and commercial labs say that a FDA policy allowing some serology tests to be used without agency review could allow inaccurate tests onto the U.S. market, which could distort crucial data on how many people have been infected.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Shortage of Test Components Forces Labs to Beg, Borrow and ImproviseAs diagnostic testing continues to pick up speed in the U.S., shortages of some supplies and a backlog of samples have pushed hospitals, academic medical centers and labs to create their own patchwork solutions.
Consulte Mais informação »
Labs around the world race to find vaccineWATCH: Labs around the world race to find COVID-19 vaccine. At least 45 countries are working hand in hand with the World Health Organization as part of a unified effort.
Consulte Mais informação »
HHS Supports State, Territorial and Tribal Public Health Labs with COVID-19 Rapid Point-of-Care TestThe U.S. Department of Health and Human Services is purchasing the ID NOW COVID-19 rapid point-of-care test, developed by Abbott Diagnostics Scarborough Inc., for state, territorial and tribal public health labs. The ID NOW COVID-19 test is performed on the ID NOW device. This test allows for medical diagnostic testing at the time and place of patient care, provides COVID-19 results in under 13 minutes and expands the capacity for coronavirus testing for individuals exhibiting symptoms as well as for healthcare professionals and the first responder community. Additionally, this will save Personal Protective Equipment (PPE) and ensure our critical workforce is safe and able to support the response, as only gloves and a facemask are necessary to administer this rapid point-of-care test.
Consulte Mais informação »
Stocks aim for back-to-back gains as investors focus on coronavirus case tallyU.S. stocks opened sharply higher on Tuesday, on track to consolidate their gains from the day before, amid hopes that the rate of increase in COVID-19 cases...
Consulte Mais informação »
Opinion | The Coronavirus Threat South of the BorderFrom WSJopinion: Latin America isn’t ready for Covid-19. Infected migrants could flee to the U.S., writes wrmead.
Consulte Mais informação »
The Masters Moves to November as Golf Repositions with a Delayed ScheduleThe Masters, which would have been played this week but was called off in response to the novel coronavirus, will be played in November
Consulte Mais informação »